Detrimental effects of poorly controlled acute pain after abdominal surgery range from patient suffering, distress, respiratory complications, delirium, myocardial ischaemia, prolonged hospital stay and an increased likelihood of chronic pain. Traditionally, patients undergoing major abdominal surgery have received systemic drugs, such as opioids, ketamine, nonsteroidal anti-inflammatory drugs (NSAIDs), alpha-2 agonists and paracetamol or epidural analgesia as part of their postoperative pain management. Peripheral nerve blockade is an alternative means of providing analgesia, by anesthetising the sensory nerves conveying pain impulses from the incision site to the spinal cord and brain.
INTRODUCTION
Poorly controlled acute pain after abdominal surgery is associated with a variety of unwanted postoperative consequences, including patient suffering, distress, respiratory complications, delirium, myocardial ischaemia, prolonged hospital stay and an increased likelihood of chronic pain. 1 A major contributor to the pain experienced after abdominal surgery is pain from the incision made in the abdominal wall, 2 with the remainder resulting from internal visceral trauma. Traditionally, analgesia for abdominal surgery is provided either by systemic drugs, such as opioids, ketamine,
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nonsteroidal anti-inflammatory drugs (NSAIDs), alpha-2 agonists and paracetamol, or by epidural anaesthesia. 3 Peripheral nerve blockade is an alternative means of providing analgesia, by anaesthetising the sensory nerves conveying pain impulses from the incision site to the spinal cord and brain.
The transversus abdominis plane (TAP) block is a peripheral nerve block which anaesthetises the abdominal wall. Although, this technique was first specifically described in 2004, variations have been used by anaesthetists for decades without becoming widely adopted. 4 The TAP block may have followed the same fate but for the advent of ultrasound as a means of localising the nerves for block placement. Its proponents suggest that analgesia provided by the TAP block is equal or superior to that provided by systemic opioids, such as morphine. It is also claimed that postoperative opioid consumption and opioid-derived adverse effects can be reduced. 5 Furthermore, the TAP block may have a lower risk of complications and greater acceptability to patients than epidural analgesia.
Several anatomical approaches to the TAP have been described. More recently, a 'subcostal' injection has been described, in which local anaesthetic is delivered into the same anatomical plane, but using an insertion point near the xiphoid process, and a needle path parallel to the costal margin. 6 It has been proposed that this approach offers superior analgesia for incisions superior to the umbilicus.
Any landmark-based regional anaesthetic technique raises two important issues. The first is the accuracy of placement of the needle and thus the local anaesthetic in a 'blind' technique. The second issue is the potential for damage to adjacent structures from blind placement of the needle. Although, ultrasound guidance improves the success rate and decreases incidence of complications in comparison to landmark-based techniques, however, from the point of view of health economics, this is not reason enough for its use as a first-choice procedure. It must be acceptable to patients, and in a not-for-profit organisation, the use of scarce resources in healthcare should represent 'good value for money'. That is, the decision to implement US should be based on solid evidence of clinical health outcomes and cost-effectiveness.
Studies have estimated that the higher acquisition costs of US equipment are counterbalanced by the possible savings with US guidance due to increased efficacy of nerve block performance, shorter onset time, and higher success rate of surgical anaesthesia.
The purpose of this study is to conduct a cost-effectiveness analysis of US guidance for postoperative bilateral TAP block vs landmark-guided epidural block in elective patients undergoing major gynaecologic oncological surgery. The hypothesis was that US guidance for TAP block is costeffective compared with continuous epidural infusion in managing postoperative analgesia.
METHODS

Health Economic Evaluation
The cost-effectiveness analysis follows international guidelines for health economic evaluations conducted alongside clinical trials. 7, 8 A health economic evaluation is a comparative analysis of costs and consequences of two or more alternative health technologies. The purpose of a health economic evaluation is to serve as an input for decisionmaking. The most common types of health economic evaluations are cost-effectiveness analyses and cost-utility analyses. The viewpoint of the analysis is a hospital sector perspective with the patients admitted during the entire study period.
The efficacy outcomes were drawn from a randomised controlled trial conducted at our Institute in which a total of 50 patients were recruited. Women were invited to participate in this study when scheduled to undergo elective open major surgery for known or presumed gynaecological malignancy via midline incision. Written informed consent was obtained. Participants were excluded if they were unable or unwilling to give informed consent to participate, less than 18 years of age, were currently using analgesics or had current acute or chronic pain, systemic infection, coagulopathy, inability to comprehend the numeric rating scale (NRS), communicative disability, dementia, BMI >35 or had an allergy or contraindication to any drug being used in the study. Randomisation was done by a computer generated sequence of random numbers and sealed envelope technique. The sample size estimation was based on the expected difference in SR between the two study groups. The primary outcome of the cost-effectiveness analysis was the incremental cost-effectiveness ratio (ICER) calculated as the difference in the mean cost between the two procedures.
Group E patients had an epidural catheter placed before surgery although the activation was done only after wound closure. Group T received an USG-guided bilateral TAP block after wound closure. Drugs used: 0.2% Ropivacaine + 2 mcg/ml Fentanyl as continuous epidural infusion postoperatively and 0.2% Ropivacaine-20 ml on each side for TAP block. All patients received a standardised general anaesthetic with multimodal analgesia. Data for resource usage and unit costs were collected prospectively during the randomised controlled trial. The costs were calculated for the first 24 postoperative hours. According to international guidelines for health economic evaluation, only marginal costs have been collected, that is, the costs that differ between the two alternative techniques. Marginal costs include the difference in resource usage between the two study groups with respect to: • Postoperative surveillance of the patients (nurse); • Medicine (Ropivacaine and Fentanyl) (including costs of syringes, syringe pumps, and other disposables); • Time used for bedside administration of medicine (nurse); • Costs of US equipment.
When US is used as an alternative to NS, it generates extra marginal costs for sterile transducer covers, sterile gel, and sterile disinfectant towels for transducer cleansing. These costs were added to the US equipment costs.
STATISTICAL ANALYSIS
Data were analysed by the intention-to-treat principle. The patient characteristics were compared using the t-test for continuous variables and the  2 test for categorical variables. The mean costs and effects were calculated for each group in the trial. Nonparametric bootstrapping was applied to estimate the standard error and the confidence interval for the mean costs and effects. The nonparametric bias-corrected bootstrapping method was used to test the robustness of the cost-effectiveness result in a multi-way analysis. All statistical analyses were carried out using Stata version 11. Table 1 shows demographic data which were not statistically different between the two groups. Table 2 shows the marginal costs of each group. Table 3 shows the mean SR. The mean ICER can be calculated from the data in and as the difference in the mean cost between the two groups divided by the mean difference in SR between them (103.5-141)/(0.94-0.79). Incremental cost-effectiveness ratio is negative meaning that US is a dominant technology that leads to better clinical outcome and lower costs. The test of the robustness of this result showed that US was better and cheaper (i.e. dominant) in ~85% of the bootstrap replications meaning that there is a probability of 85% that US will lead to higher quality and lower costs. The mean difference in the effect is significant (p <0.05) by suing Chi-square test.
RESULTS
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DISCUSSION
Our study is the first health economic evaluation of USG guided TAP block vs landmark guided epidural block for the first 24 hours postoperatively. The marginal costs evaluated in this study include 'time' variables because in health economic evaluations, time is per definition a cost and is not the same as salaries. The true marginal value of time may indeed be both higher and lower than the gross salaries paid per effective hour of labour, which is the standard way of estimating the opportunity cost of physicians and nurses in health economic evaluation. 7 The aim of any health economic evaluation is to identify when we can be confident that one health technology is 'good value' compared with another. A single trial may not reflect the true result in the population because of stochastic uncertainty. This study quantifies the stochastic uncertainty in the cost-effectiveness result by performing a nonparametric bootstrap analysis to build an empirical estimate of the sampling distribution of the ICER. This approach has been recommended for statistical analyses in economic evaluations conducted alongside clinical trials. 7, 8 However, there are certain limitations of our study. We have not included the costs involved in training for USG guided TAP blocks as compared to the traditionally practised epidural blocks. Also, the multitude of applications that an USG machine can be used for have not been accounted for. To conclude, USG guided bilateral TAP blocks are more cost-effective than continuous epidurals in the first 24 hours postoperatively in patients undergoing midline laparotomy for gynaecologic oncologic surgeries. Thus, in patients with contraindications to epidural blocks can have them as a part of their multimodal analgesia plan.
